Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside. - Wikidata - awgldk - TriplyDB

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

http://www.wikidata.org/entity/Q37683451

about

The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu

P2860

Q33907274-B91A2A1D-0774-4B60-BD3F-D47387D56CBB Q47114899-CA960CC6-B62D-46E3-A31B-FAA58B01112B Q58781616-28C54C80-4745-45CF-83B2-77AA2CFB2A43

P2860

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

http://www.wikidata.org/entity/Q37683451

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@en

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@nl

type

label

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@en

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@nl

prefLabel

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@en

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@nl

P1433

Q37683451-4565E5BE-D3DE-4CA8-8804-6DFD026FF978

P1476

Q37683451-40DEC6EE-28E4-4A41-822C-DDAA2904ED2A

P2093

Q37683451-9D3E77F2-789B-4EE3-8C2F-946D66C53C76

Q37683451-9E39ACAE-A785-42CE-937D-DABDF881D403

P275

Q37683451-B7A9BBAC-8FC3-4469-A776-87AF34560FA7

P2860

Q37683451-0ACE058B-71E1-48F5-B641-203958F29138

Q37683451-10D8277B-6851-4F3D-9C5B-F15DA37F659A

Q37683451-1E16CB31-85D7-4102-A22D-EDC16734CBF6

Q37683451-237746A5-5A28-4B64-9DD5-C9CAA9C27DBE

Q37683451-3180BC82-DE32-4D56-8E62-9015CFE706C7

Q37683451-38C86B2C-E8DE-4DF8-B3AC-485997E14D36

Q37683451-3EDA5B86-3A0F-44B7-ADC4-9EF81EB8BDEF

Q37683451-4836D2F7-1182-44C6-9D6B-A043A90B0CB0

Q37683451-48B7AD24-7CE4-4BD1-A22A-7873744EE33E

Q37683451-6456381F-4620-4CFC-BF06-D91567559A07

P304

Q37683451-7524BA5D-DB72-4209-854B-0BEBA6F8A2E5

P31

Q37683451-2C873F88-7E71-47FF-B995-4A3D25743C99

Q37683451-B3FD7C04-61A7-458F-9ADC-1300A0B41E36

P356

Q37683451-EE5A6382-677A-4DE1-AC13-69FADF80AB69

P433

Q37683451-89D5BB1E-61BC-4F7B-9421-4D0EF7F6FCEE

P478

Q37683451-8D4D9536-7F99-4C7D-923C-46A0CDBD2C5E

P50

Q37683451-1F818250-C503-4A9F-9576-8ABEC843BABB

P5008

Q37683451-D6A09B79-723F-41C0-9AB6-632C8D956ED6

P577

Q37683451-3CDE9742-B2E4-4508-BF74-BAB36284727D

Q37683451-EFB9E492-4C03-4A4E-8515-2DA63B5C782A

P698

Q37683451-E7EB2E19-67B2-460D-AACF-57DB36AAAFFC

P921

Q37683451-02BF66E6-C711-48E0-A2DF-16244D9A15F3

Q37683451-7C834FA6-5969-4D86-BFEF-CA06821FF2BF

Q37683451-7F5A095F-72DA-4C85-8AE0-A5F1A3ABBE9E

Q37683451-CA687AB9-4200-4EF6-B2C5-A7FE2966E5F6

Q37683451-D331D069-8058-4639-8CA6-4FAF10FD7427

Q37683451-DDDF23D1-B9CE-4E3D-9994-BFBE2745BA05

P932

Q37683451-093CD3E6-F850-4DDB-8E2B-B37E1D1EC0E9

P356

P1433

The Korean journal of internal medicine

P1476

Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.

@en

P2093

Byung-Sik Cho

http://www.w3.org/2001/XMLSchema#string

Hee-Je Kim

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence

DNMT3A Mutations in Acute Myeloid Leukemia

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)

CXCL12 (SDF-1)/CXCR4 pathway in cancer.

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity.

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2016.244

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Marina Konopleva

P5008

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28219003

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

acute myeloid leukemia

membrane proteins

virus receptors

P932

5339474

http://www.w3.org/2001/XMLSchema#string